Steeve Boulant, Ph.D - Publications

Affiliations: 
Virology University of Heidelberg, Germany, Heidelberg, Baden-Württemberg, Germany 
Area:
Virology, Innate Immunity, Clathrin mediated endocytosis
Website:
boulantlab.com

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Uckeley ZM, Duboeuf M, Gu Y, Erny A, Mazelier M, Lüchtenborg C, Winter SL, Schad P, Mathieu C, Koch J, Boulant S, Chlanda P, Maisse C, Brügger B, Lozach PY. Glucosylceramide in bunyavirus particles is essential for virus binding to host cells. Cellular and Molecular Life Sciences : Cmls. 81: 71. PMID 38300320 DOI: 10.1007/s00018-023-05103-0  0.365
2023 Adam L, Stanifer M, Springer F, Mathony J, Brune M, Di Ponzio C, Eils R, Boulant S, Niopek D, Kallenberger SM. Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells. Science Signaling. 16: eabl8266. PMID 37751479 DOI: 10.1126/scisignal.abl8266  0.372
2022 Karlowitz R, Stanifer ML, Roedig J, Andrieux G, Bojkova D, Bechtel M, Smith S, Kowald L, Schubert R, Boerries M, Cinatl J, Boulant S, van Wijk SJL. USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. Cell Death & Disease. 13: 684. PMID 35933402 DOI: 10.1038/s41419-022-05124-w  0.305
2022 Laise P, Stanifer ML, Bosker G, Sun X, Triana S, Doldan P, La Manna F, De Menna M, Realubit RB, Pampou S, Karan C, Alexandrov T, Kruithof-de Julio M, Califano A, Boulant S, et al. A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. Communications Biology. 5: 714. PMID 35854100 DOI: 10.1038/s42003-022-03663-8  0.321
2022 Petitjean SJL, Chen W, Koehler M, Jimmidi R, Yang J, Mohammed D, Juniku B, Stanifer ML, Boulant S, Vincent SP, Alsteens D. Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection. Nature Communications. 13: 2564. PMID 35538121 DOI: 10.1038/s41467-022-30313-8  0.301
2022 Laise P, Stanifer M, Bosker G, Sun X, Triana S, Doldan P, Manna F, De Menna M, Realubit R, Pampou S, Karan C, Alexandrov T, Julio MK, Califano A, Boulant S, et al. A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection. Research Square. PMID 35132404 DOI: 10.21203/rs.3.rs-1287631/v1  0.331
2022 Becker J, Stanifer ML, Leist SR, Stolp B, Maiakovska O, West A, Wiedtke E, Börner K, Ghanem A, Ambiel I, Tse LV, Fackler OT, Baric RS, Boulant S, Grimm D. Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV-RNAi expression vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35038579 DOI: 10.1016/j.ymthe.2022.01.024  0.305
2021 Triana S, Stanifer ML, Metz-Zumaran C, Shahraz M, Mukenhirn M, Kee C, Serger C, Koschny R, Ordoñez-Rueda D, Paulsen M, Benes V, Boulant S, Alexandrov T. Single-cell transcriptomics reveals immune response of intestinal cell types to viral infection. Molecular Systems Biology. 17: e9833. PMID 34309190 DOI: 10.15252/msb.20209833  0.307
2021 Koch J, Uckeley ZM, Doldan P, Stanifer M, Boulant S, Lozach PY. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. The Embo Journal. e107821. PMID 34159616 DOI: 10.15252/embj.2021107821  0.35
2020 Cortese M, Lee JY, Cerikan B, Neufeldt CJ, Oorschot VMJ, Köhrer S, Hennies J, Schieber NL, Ronchi P, Mizzon G, Romero-Brey I, Santarella-Mellwig R, Schorb M, Boermel M, Mocaer K, ... ... Boulant S, et al. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies. Cell Host & Microbe. PMID 33245857 DOI: 10.1016/j.chom.2020.11.003  0.338
2020 Tekes G, Ehmann R, Boulant S, Stanifer ML. Development of Feline Ileum- and Colon-Derived Organoids and Their Potential Use to Support Feline Coronavirus Infection. Cells. 9. PMID 32932592 DOI: 10.3390/Cells9092085  0.351
2020 Léger P, Nachman E, Richter K, Tamietti C, Koch J, Burk R, Kummer S, Xin Q, Stanifer M, Bouloy M, Boulant S, Kräusslich HG, Montagutelli X, Flamand M, Nussbaum-Krammer C, et al. NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice. Nature Communications. 11: 3281. PMID 32612175 DOI: 10.1038/S41467-020-17101-Y  0.349
2020 Kounatidis I, Stanifer ML, Phillips MA, Paul-Gilloteaux P, Heiligenstein X, Wang H, Okolo CA, Fish TM, Spink MC, Stuart DI, Davis I, Boulant S, Grimes JM, Dobbie IM, Harkiolaki M. 3D Correlative Cryo-Structured Illumination Fluorescence and Soft X-ray Microscopy Elucidates Reovirus Intracellular Release Pathway. Cell. PMID 32610083 DOI: 10.1016/J.Cell.2020.05.051  0.496
2020 Stanifer ML, Kee C, Cortese M, Zumaran CM, Triana S, Mukenhirn M, Kraeusslich HG, Alexandrov T, Bartenschlager R, Boulant S. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Cell Reports. 32: 107863. PMID 32610043 DOI: 10.1016/J.Celrep.2020.107863  0.423
2020 Woelfl F, Léger P, Oreshkova N, Pahmeier F, Windhaber S, Koch J, Stanifer M, Roman Sosa G, Uckeley ZM, Rey FA, Boulant S, Kortekaas J, Wichgers Schreur PJ, Lozach PY. Novel Toscana Virus Reverse Genetics System Establishes NSs as an Antagonist of Type I Interferon Responses. Viruses. 12. PMID 32260371 DOI: 10.3390/V12040400  0.43
2020 Wiegand T, Fratini M, Frey F, Yserentant K, Liu Y, Weber E, Galior K, Ohmes J, Braun F, Herten DP, Boulant S, Schwarz US, Salaita K, Cavalcanti-Adam EA, Spatz JP. Forces during cellular uptake of viruses and nanoparticles at the ventral side. Nature Communications. 11: 32. PMID 31896744 DOI: 10.1038/S41467-019-13877-W  0.717
2019 Stanifer ML, Mukenhirn M, Muenchau S, Pervolaraki K, Kanaya T, Albrecht D, Odendall C, Hielscher T, Haucke V, Kagan JC, Bartfeld S, Ohno H, Boulant S. Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells. Nature Microbiology. PMID 31686029 DOI: 10.1038/S41564-019-0594-3  0.342
2019 Bilz NC, Willscher E, Binder H, Böhnke J, Stanifer ML, Hübner D, Boulant S, Liebert UG, Claus C. Teratogenic Rubella Virus Alters the Endodermal Differentiation Capacity of Human Induced Pluripotent Stem Cells. Cells. 8. PMID 31405163 DOI: 10.3390/Cells8080870  0.385
2019 Pervolaraki K, Guo C, Albrecht D, Boulant S, Stanifer ML. Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 31199715 DOI: 10.1089/Jir.2019.0040  0.365
2019 Stanifer ML, Pervolaraki K, Boulant S. Differential Regulation of Type I and Type III Interferon Signaling. International Journal of Molecular Sciences. 20. PMID 30901970 DOI: 10.3390/Ijms20061445  0.302
2019 Fakhiri J, Schneider MA, Puschhof J, Stanifer M, Schildgen V, Holderbach S, Voss Y, El Andari J, Schildgen O, Boulant S, Meister M, Clevers H, Yan Z, Qiu J, Grimm D. Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses. Molecular Therapy. Methods & Clinical Development. 12: 202-222. PMID 30766894 DOI: 10.1016/J.Omtm.2019.01.003  0.339
2018 Pervolaraki K, Rastgou Talemi S, Albrecht D, Bormann F, Bamford C, Mendoza JL, Garcia KC, McLauchlan J, Höfer T, Stanifer ML, Boulant S. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. Plos Pathogens. 14: e1007420. PMID 30485383 DOI: 10.1371/Journal.Ppat.1007420  0.339
2018 Fratini M, Wiegand T, Funaya C, Jiang Z, Shah PNM, Spatz J, Cavalcanti-Adam EA, Boulant S. Surface Immobilization of Viruses and Nanoparticles Elucidates Early Events in Clathrin-mediated Endocytosis. Acs Infectious Diseases. PMID 30200751 DOI: 10.1021/Acsinfecdis.8B00134  0.712
2018 Boulant S. Assaying the Contribution of Membrane Tension to Clathrin-Mediated Endocytosis. Methods in Molecular Biology (Clifton, N.J.). 1847: 37-50. PMID 30129008 DOI: 10.1007/978-1-4939-8719-1_4  0.367
2018 Scheffler K, Claus C, Stanifer ML, Boulant S, Reibetanz U. Reversible Fusion Proteins as a Tool to Enhance Uptake of Virus-Functionalized LbL Microcarriers. Biomacromolecules. PMID 29966082 DOI: 10.1021/Acs.Biomac.8B00360  0.377
2018 Bucher D, Frey F, Sochacki KA, Kummer S, Bergeest JP, Godinez WJ, Kräusslich HG, Rohr K, Taraska JW, Schwarz US, Boulant S. Clathrin-adaptor ratio and membrane tension regulate the flat-to-curved transition of the clathrin coat during endocytosis. Nature Communications. 9: 1109. PMID 29549258 DOI: 10.1038/S41467-018-03533-0  0.37
2017 Dräger NM, Nachman E, Winterhoff M, Brühmann S, Shah P, Katsinelos T, Boulant S, Teleman AA, Faix J, Jahn TR. Bin1 directly remodels actin dynamics through its BAR domain. Embo Reports. PMID 28893863 DOI: 10.15252/Embr.201744137  0.551
2017 Stanifer ML, Kischnick C, Rippert A, Albrecht D, Boulant S. Reovirus inhibits interferon production by sequestering IRF3 into viral factories. Scientific Reports. 7: 10873. PMID 28883463 DOI: 10.1038/S41598-017-11469-6  0.442
2017 Shah PNM, Stanifer ML, Höhn K, Engel U, Haselmann U, Bartenschlager R, Kräusslich HG, Krijnse-Locker J, Boulant S. Genome packaging of Reovirus is mediated by the scaffolding property of the microtubule network. Cellular Microbiology. PMID 28672089 DOI: 10.1111/Cmi.12765  0.423
2017 Pervolaraki K, Stanifer ML, Münchau S, Renn LA, Albrecht D, Kurzhals S, Senís E, Grimm D, Schröder-Braunstein J, Rabin RL, Boulant S. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut. Frontiers in Immunology. 8: 459. PMID 28484457 DOI: 10.3389/Fimmu.2017.00459  0.363
2016 Stanifer ML, Rippert A, Kazakov A, Willemsen J, Bucher D, Bender S, Bartenschlager R, Binder M, Boulant S. Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF-β dependent pro-survival signaling. Cellular Microbiology. PMID 27279006 DOI: 10.1111/Cmi.12626  0.396
2016 Pujol FM, Laketa V, Schmidt F, Mukenhirn M, Müller B, Boulant S, Grimm D, Keppler OT, Fackler OT. HIV-1 Vpu Antagonizes CD317/tetherin by Adaptor protein-1-Mediated Exclusion from Virus Assembly Sites. Journal of Virology. PMID 27170757 DOI: 10.1128/Jvi.00504-16  0.304
2015 Boulant S, Stanifer M, Lozach PY. Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis. Viruses. 7: 2794-815. PMID 26043381 DOI: 10.3390/V7062747  0.444
2014 Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nature Immunology. 15: 717-26. PMID 24952503 DOI: 10.1038/Ni.2915  0.332
2014 Kural C, Boulant S, Kirchhausen T. Dynamics of Intracellular Clathrin Carriers Biophysical Journal. 106: 310a. DOI: 10.1016/J.Bpj.2013.11.1794  0.337
2013 Blaising J, Lévy PL, Polyak SJ, Stanifer M, Boulant S, Pécheur EI. Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking. Antiviral Research. 100: 215-9. PMID 23981392 DOI: 10.1016/J.Antiviral.2013.08.008  0.5
2013 Blaising J, Lévy PL, Gondeau C, Phelip C, Varbanov M, Teissier E, Ruggiero F, Polyak SJ, Oberlies NH, Ivanovic T, Boulant S, Pécheur EI. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cellular Microbiology. 15: 1866-82. PMID 23701235 DOI: 10.1111/Cmi.12155  0.708
2013 Boulant S, Stanifer M, Kural C, Cureton DK, Massol R, Nibert ML, Kirchhausen T. Similar uptake but different trafficking and escape routes of reovirus virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells. Molecular Biology of the Cell. 24: 1196-207. PMID 23427267 DOI: 10.1091/Mbc.E12-12-0852  0.616
2012 Kural C, Tacheva-Grigorova SK, Boulant S, Cocucci E, Baust T, Duarte D, Kirchhausen T. Dynamics of intracellular clathrin/AP1- and clathrin/AP3-containing carriers. Cell Reports. 2: 1111-9. PMID 23103167 DOI: 10.1016/J.Celrep.2012.09.025  0.309
2012 Cocucci E, Aguet F, Boulant S, Kirchhausen T. The first five seconds in the life of a clathrin-coated pit. Cell. 150: 495-507. PMID 22863004 DOI: 10.1016/J.Cell.2012.05.047  0.355
2012 Strang BL, Boulant S, Kirchhausen T, Coen DM. Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments. Mbio. 3. PMID 22318319 DOI: 10.1128/Mbio.00301-11  0.39
2012 Strang BL, Boulant S, Chang L, Knipe DM, Kirchhausen T, Coen DM. Human cytomegalovirus UL44 concentrates at the periphery of replication compartments, the site of viral DNA synthesis. Journal of Virology. 86: 2089-95. PMID 22156516 DOI: 10.1128/Jvi.06720-11  0.348
2011 Boulant S, Kural C, Zeeh JC, Ubelmann F, Kirchhausen T. Actin dynamics counteract membrane tension during clathrin-mediated endocytosis. Nature Cell Biology. 13: 1124-31. PMID 21841790 DOI: 10.1038/Ncb2307  0.351
2011 Ivanovic T, Boulant S, Ehrlich M, Demidenko AA, Arnold MM, Kirchhausen T, Nibert ML. Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking. Traffic (Copenhagen, Denmark). 12: 1179-95. PMID 21736684 DOI: 10.1111/J.1600-0854.2011.01233.X  0.738
2011 Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, Bleackley RC, Kirchhausen T, Lieberman J. Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells. Nature Immunology. 12: 770-7. PMID 21685908 DOI: 10.1038/Ni.2050  0.318
2011 Kural C, Boulant S, Kirchhausen T. Real-Time Imaging of Clathrin Dynamics in Three Dimensions Biophysical Journal. 100: 30a. DOI: 10.1016/J.Bpj.2010.12.369  0.386
2010 Targett-Adams P, Boulant S, Douglas MW, McLauchlan J. Lipid metabolism and HCV infection. Viruses. 2: 1195-217. PMID 21994676 DOI: 10.3390/V2051195  0.34
2010 Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 141: 668-81. PMID 20451243 DOI: 10.1016/J.Cell.2010.04.018  0.574
2010 Strang BL, Boulant S, Coen DM. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. Journal of Virology. 84: 1771-84. PMID 20007282 DOI: 10.1128/Jvi.01510-09  0.426
2010 Angus AG, Dalrymple D, Boulant S, McGivern DR, Clayton RF, Scott MJ, Adair R, Graham S, Owsianka AM, Targett-Adams P, Li K, Wakita T, McLauchlan J, Lemon SM, Patel AH. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. The Journal of General Virology. 91: 122-32. PMID 19793905 DOI: 10.1099/Vir.0.015909-0  0.478
2009 Roohvand F, Maillard P, Lavergne JP, Boulant S, Walic M, Andréo U, Goueslain L, Helle F, Mallet A, McLauchlan J, Budkowska A. Initiation of hepatitis C virus infection requires the dynamic microtubule network: Role of the viral nucleocapsid protein Journal of Biological Chemistry. 284: 13778-13791. PMID 19269968 DOI: 10.1074/Jbc.M807873200  0.459
2009 Ratinier M, Boulant S, Crussard S, McLauchlan J, Lavergne JP. Subcellular localizations of the hepatitis C virus alternate reading frame proteins Virus Research. 139: 106-110. PMID 18996421 DOI: 10.1016/J.Virusres.2008.09.011  0.373
2008 Ratinier M, Boulant S, Combet C, Targett-Adams P, McLauchlan J, Lavergne JP. Transcriptional slippage prompts recoding in alternate reading frames in the hepatitis C virus (HCV) core sequence from strain HCV-1. The Journal of General Virology. 89: 1569-78. PMID 18559926 DOI: 10.1099/Vir.0.83614-0  0.379
2008 Boulant S, Douglas MW, Moody L, Budkowska A, Targett-Adams P, McLauchlan J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic (Copenhagen, Denmark). 9: 1268-82. PMID 18489704 DOI: 10.1111/J.1600-0854.2008.00767.X  0.471
2008 Targett-Adams P, Hope G, Boulant S, McLauchlan J. Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. The Journal of Biological Chemistry. 283: 16850-9. PMID 18424431 DOI: 10.1074/Jbc.M802273200  0.393
2008 Targett-Adams P, Boulant S, McLauchlan J. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. Journal of Virology. 82: 2182-95. PMID 18094154 DOI: 10.1128/Jvi.01565-07  0.434
2007 Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. The Journal of Biological Chemistry. 282: 37158-69. PMID 17942391 DOI: 10.1074/Jbc.M707329200  0.446
2007 Boulant S, Targett-Adams P, McLauchlan J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. The Journal of General Virology. 88: 2204-13. PMID 17622624 DOI: 10.1099/Vir.0.82898-0  0.437
2007 Fiorucci M, Boulant S, Fournillier A, Abraham JD, Lavergne JP, Paranhos-Baccala G, Inchauspé G, Bain C. Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries. The Journal of General Virology. 88: 1149-62. PMID 17374758 DOI: 10.1099/Vir.0.82575-0  0.378
2006 Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, Lavergne JP, Penin F, McLauchlan J. Structural determinants that target the hepatitis C virus core protein to lipid droplets. The Journal of Biological Chemistry. 281: 22236-47. PMID 16704979 DOI: 10.1074/Jbc.M601031200  0.364
2005 Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne JP. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features Journal of Virology. 79: 11353-11365. PMID 16103187 DOI: 10.1128/Jvi.79.17.11353-11365.2005  0.394
2005 Boni S, Lavergne JP, Boulant S, Cahour A. Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA Journal of Biological Chemistry. 280: 17737-17748. PMID 15760888 DOI: 10.1074/Jbc.M501826200  0.365
2004 Cristofari G, Ivanyi-Nagy R, Gabus C, Boulant S, Lavergne JP, Penin F, Darlix JL. The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro. Nucleic Acids Research. 32: 2623-31. PMID 15141033 DOI: 10.1093/Nar/Gkh579  0.421
2003 Boulant S, Becchi M, Penin F, Lavergne JP. Unusual Multiple Recoding Events Leading to Alternative Forms of Hepatitis C Virus Core Protein from Genotype 1b Journal of Biological Chemistry. 278: 45785-45792. PMID 12952944 DOI: 10.1074/Jbc.M307174200  0.399
Show low-probability matches.